An interview strategy was critical for obtaining valid information on the use of hormone replacement therapy.

J Clin Epidemiol

Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA.

Published: November 2004

Objective: We compared telephone reports of hormone replacement therapy (HRT) use to claims for drugs dispensed.

Study Design And Setting: The study subjects included 106 women who were dispensed HRT and 107 who were not dispensed HRT.

Results: Recall of drug use overall was relatively good (65/79=82.3%, 95% confidence interval [CI] 73.9-90.7). Agreement between recall of drug name and the claims for dispensed drugs was lower (61/79=77.2%, 95% CI 68.0-86.5). Of 65 women reporting use of HRT in response to the indication prompt, nine (13.8%) could not identify the drug name using the drug list prompt, but all 65 women identified a drug using the photo prompt. Recall of start date of drug use was poor (29.2% agreement on month/year; 45.8% agreement within 1 month), and recall of end date of drug use was poorer yet (7.7% agreement on month/year; 21.5% agreement within 1 month).

Conclusion: Recall of drug use and drug names is far better than recall of dates of use. Recall can be enhanced with lists of drug names and color photos, but even with memory prompts, recall remains imperfect. If drug use is the primary exposure of interest in a study, considerable effort is needed to collect it correctly. If not, then perhaps drug histories should be omitted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2004.04.001DOI Listing

Publication Analysis

Top Keywords

recall drug
16
drug
12
hormone replacement
8
replacement therapy
8
recall
8
drug drug
8
agreement month/year
8
drug names
8
agreement
5
interview strategy
4

Similar Publications

Publicly available trial matching tools can improve the access to therapeutic innovations, but errors may expose to over-solicitation and disappointment. We performed a pragmatic non-interventional prospective evaluation on sequential patients at the Molecular Tumor Board of Centre Leon Berard. During 10 weeks in 2024, we analysed 157 patients with four clinical trial matching tools from the 19 screened: Klineo, ScreenAct, Trialing and DigitalECMT.

View Article and Find Full Text PDF

Background/objectives: While studies in rat pups suggest that early zinc exposure is critical for optimal brain structure and function, associations of prenatal zinc intake with measures of brain development in infants are unknown. This study aimed to assess the associations of maternal zinc intake during pregnancy with MRI measures of brain tissue microstructure and neurodevelopmental outcomes, as well as to determine whether MRI measures of the brain mediated the relationship between maternal zinc intake and neurodevelopmental indices.

Methods: Forty-one adolescent mothers were recruited for a longitudinal study during pregnancy.

View Article and Find Full Text PDF

As part of the U.S. Food and Drug Administration's (FDA's) Closer to Zero initiative, a toxicological reference value (TRV) for oral dietary exposure to Cd was established.

View Article and Find Full Text PDF

This study introduces a novel AI-driven approach to support elderly patients in Thailand with medication management, focusing on accurate drug label interpretation. Two model architectures were explored: a Two-Stage Optical Character Recognition (OCR) and Large Language Model (LLM) pipeline combining EasyOCR with Qwen2-72b-instruct and a Uni-Stage Visual Question Answering (VQA) model using Qwen2-72b-VL. Both models operated in a zero-shot capacity, utilizing Retrieval-Augmented Generation (RAG) with DrugBank references to ensure contextual relevance and accuracy.

View Article and Find Full Text PDF

Introduction: Clinical trials are critical for drug development and patient care; however, they often need more efficient trial design and patient enrolment processes. This research explores integrating machine learning (ML) techniques to address these challenges. Specifically, the study investigates ML models for two critical aspects: (1) streamlining clinical trial design parameters (like the site of drug action, type of Interventional/Observational model, etc) and (2) optimizing patient/volunteer enrolment for trials through efficient classification techniques.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!